Skip to Main Content (Press Enter)

Logo UNIME
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Expertise & Skills

Expertise & Skills
Logo UNIME

|

UNIFIND - Expertise & Skills

unime.it
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Expertise & Skills
  1. Outputs

BRITISH JOURNAL OF HAEMATOLOGY

Journal
Identifier:
E025360
ISSN:
0007-1048
  • Overview

Overview

Outputs (29)

  • ascendant
  • decrescent
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy.
Academic Article
AN UNUSUAL PRESENTATION OF SCHISTOSOMIASIS
Academic Article
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report
Academic Article
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias
Academic Article
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report
Academic Article
Disseminated molluscum contagiosum in a patient with chronic lymphocytic leukaemia after alemtuzumab
Academic Article
HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy.
Academic Article
HIF1α and Glut1 receptor in transfused and untransfused thalassemic patients
Academic Article
High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
Academic Article
Increased phospho-mTOR expression in megakaryocytic cells derived from CD34+ progenitors of essential thrombocythaemia and myelofibrosis patients
Academic Article
Is ZAP70 still a key prognostic factor in early stage chronic lymphocytic leukaemia? Results of the analysis from a prospective multicentre observational study.
Academic Article
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations
Academic Article
MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma
Academic Article
Multidrug resistance mechanisms in chronic lymphocytic leukaemia
Academic Article
Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia
Academic Article
Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib
Academic Article
RAPID REVERSION OF EOSINOPHILIC GASTROENTERITIS AFTER TARGET THERAPY WITH IMATINIB
Academic Article
Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease
Academic Article
Reshaping the therapeutic landscape of chronic lymphocytic leukaemia in the era of targeted therapy
Academic Article
Risk factors and reasons for switching from front-line therapy in the Italian chronic myeloid leukaemia network: A cohort study
Academic Article
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response
Academic Article
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response.
Academic Article
Systematic screening for HCV infection should be performed in patients with splenic marginal zone lymphoma
Academic Article
Thalassaemia major and infectious risk: High Mobility Group Box-1 represents a novel diagnostic and prognostic biomarker
Academic Article
Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF
Academic Article
Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF.
Academic Article
The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
Academic Article
Underlying disease is the main risk factor in post-splenectomy complication risk: Data from a national database.
Academic Article
Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemia
Academic Article
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} of {itemsNumber}
  • Guide
  • Help
  • Accessibility
  • Privacy
  • Use of cookies
  • Legal notes

Powered by VIVO | Designed by Cineca | 26.4.5.0